Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2024DD995512Published 16 Sept 2024France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du conseil d'administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€423,842.90
Net buy/sell
-€423,842.90
Other reported value
€0.00
Gross reported value
€423,842.90
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 10 Sept 2024 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 41,270 | €10.27 | €423,842.90 | XPAR |
Sell
Execution date10 Sept 2024Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 41,270
- Unit price
- €10.27
- Total
- €423,842.90
Evidence
- AMF · France2024DD995512
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.